Several mutations in the APOB, PCSK9, and MTP genes result in familial hypobetalipoproteinemia (FHBL) and abetalipoproteinemia (ABL) defined as low, or absent levels of apoB-100, and LDL-C in plasma [52, 53]. This evidence concerns the gene APOB and hypobetalipoproteinemia.